Home › Funds › 1060 Capital, LLC › GENI
1060 Capital, LLC position in GENI
GENIUS SPORTS LIMITED · Consumer Discretionary
1060 Capital, LLC reported holding 900,000 shares of GENI (GENIUS SPORTS LIMITED) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 7.70% of its reported portfolio and ranking #5 among its reported holdings. 1060 Capital, LLC has disclosed GENI holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 1060 Capital, LLC's GENI position evolved
1060 Capital, LLC first disclosed a stake in GENI in Q2 2024 at 350,000 shares (US$1.9M). The position peaked in Q1 2025 at 700,000 shares, worth US$7.0M. Across 4 filings, 1060 Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 900,000 shares valued at US$5.5M. Notable position changes include a 38% trim in Q3 2024 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 350.00K | $1.91M | New |
| Q3 2024 | 217.39K | $1.70M | Reduce |
| Q1 2025 | 700.00K | $7.01M | New |
| Q2 2026 | 900.00K | $5.45M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENI and 13F data
GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 25 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$59.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENI
- Senvest Management, LLC 15.88M sh · $96.24M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 13.50M sh · $81.78M · Q2 2026
- SHAPIRO CAPITAL MANAGEMENT LLC 9.89M sh · $59.92M · Q2 2026
- DISCOVERY CAPITAL MANAGEMENT, LLC / CT 7.23M sh · $43.82M · Q2 2026
- Portolan Capital Management, LLC 7.03M sh · $42.58M · Q2 2026
- Granahan Investment Management, LLC 7.02M sh · $42.57M · Q2 2026
- Voss Capital, LP 6.85M sh · $41.51M · Q2 2026
- NEEDHAM INVESTMENT MANAGEMENT LLC 4.92M sh · $29.85M · Q2 2026
- Samjo Management, LLC 4.91M sh · $29.77M · Q2 2026
- Global Alpha Capital Management Ltd. 4.44M sh · $28.17M · Q2 2026
- CYPRESS POINT INVESTMENT MANAGEMENT LP 4.15M sh · $25.16M · Q2 2026
- IFC Advisors LLC 4.05M sh · $24.56M · Q2 2026
More on 1060 Capital, LLC
FAQ
How long has 1060 Capital, LLC held GENI?
1060 Capital, LLC has disclosed GENI holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
What is 1060 Capital, LLC's current position in GENI?
As of Q2 2026, 1060 Capital, LLC holds 900.00K shares of GENI (GENIUS SPORTS LIMITED), valued at $5.45M, representing 7.70% of its reported portfolio and ranking #5.
Has 1060 Capital, LLC been buying or selling GENI?
In the latest 13F filing (Q2 2026), 1060 Capital, LLC newly opened its position in GENI. The position peaked in Q1 2025 at 700.00K shares.
Which other funds hold GENI?
Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.